![Aleksandra Rizo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Aleksandra Rizo
Directeur/Membre du Conseil chez
SYNDAX PHARMACEUTICALS, INC.
Fortune : 546 500 $ au 30/06/2026
Profil
Aleksandra Rizo is currently President, Chief Executive Officer & Director at Vividion Therapeutics, Inc. since 2023 and Independent Director at Syndax Pharmaceuticals, Inc. starting in 2024.
Former positions include Chief Medical Officer & Executive Vice President at Geron Corp.
from 2019 to 2022, Executive Director-Strategy & Clinical Leader at Celgene Corp.
from 2018 to 2019, and Senior Director & Team Leader Compound Development at Janssen Research & Development LLC from 2014 to 2018.
Education includes doctorates from the University of Groningen, the University of Tokyo, and Saints Cyril & Methodius University of Skopje.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/03/2026 | 25 000 ( 0,03 % ) | 546 500 $ | 30/06/2026 |
Postes actifs de Aleksandra Rizo
| Sociétés | Poste | Début |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 14/05/2024 |
Vividion Therapeutics, Inc.
 Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Directeur Général | 24/01/2023 |
Anciens postes connus de Aleksandra Rizo
| Sociétés | Poste | Fin |
|---|---|---|
| GERON CORPORATION | Directeur Technique/Scientifique/R&D | 08/07/2022 |
| CELGENE | Corporate Officer/Principal | 01/01/2019 |
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Corporate Officer/Principal | 01/03/2018 |
Formation de Aleksandra Rizo
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Syndax Pharmaceuticals, Inc.
 Syndax Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
University of Groningen
 University of Groningen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Tokyo
 University of Tokyo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides research and development medicines and solutions to other medical needs | Commercial Services |
Saints Cyril & Methodius University of Skopje
 Saints Cyril & Methodius University of Skopje Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vividion Therapeutics, Inc.
Vividion Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology research company which develops precision therapeutics for cancers and immune disorders | Health Technology |
